BCLI
Brainstorm Cell Therapeutics Inc.Company with tickers: BCLI
CIK
1137883
CUSIP
10501E300
Shares Outstanding
11,034,775
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | — | ||||
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | — | ||||
| Research & Development | $762,000 | USD | 2026-03-31 | 10-Q | 2026-05-15 |
| Operating Income | $-2,046,000 | USD | 2026-03-31 | 10-Q | 2026-05-15 |
| Net Income | $-2,127,000 | USD | 2026-03-31 | 10-Q | 2026-05-15 |
| EPS (Basic) | $-0.19 | USD/shares | 2026-03-31 | 10-Q | 2026-05-15 |
| EPS (Diluted) | $-0.19 | USD/shares | 2026-03-31 | 10-Q | 2026-05-15 |